Skip to main content

DarioHealth Corp.

corporate_fare Company Profile

DarioHealth Corp.

DRIO·NASDAQ·Life Sciences·CIK 0001533998

Dario is a vertically integrated health intelligence platform focused on powering behavior changes for better health. The company manages the entire chronic care management process, including connected FDA-cleared hardware devices that generate continuous physiological data, AI built on this proprietary data, and a behavior change and coaching layer supported by over 100 peer-reviewed clinical studies. Dario aims to transform healthcare through a comprehensive and engaging whole-person health platform. The company's approach emphasizes engagement, believing that many existing digital health solutions fail due to a lack of relevance, personalization, consumerization, and longitudinal data. Dario, along with its acquired companies, initially commercialized its digital behavioral health products in the direct-to-consumer (D2C) marketplace, which it continues to use for innovation. D2C consumers, who pay out-of-pocket, demand engaging user experiences that deliver strong clinical health outcomes. Dario prioritizes engagement to drive sustained behavior change and measurable health outcomes. The company believes its D2C origins and focus lead to better user experiences, longer engagement, stronger clinical outcomes, and affordable prices, resulting in high return on investment. Dario's whole-person health model includes five elements, starting with Physical Health, which addresses the prevention and treatment of physical ailments, primarily cardiometabolic and musculoskeletal conditions.

DarioHealth Corp. (NASDAQ:DRIO) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 23 items for DRIO at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-19, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 14 rated 8 or above. Recent SEC coverage for DRIO spans 10-Q, 424B5, 8-K, S-3.

Recent high-impact activity:

  • Dario Lands WebMD Distribution Deal Reaching 65 Million Covered Lives
  • DarioHealth Posts $5.3M Q3 Revenue as Covenant Breach Looms
  • DarioHealth Q3 Loss Narrows to $8.8M; Covenant Cured With $22.8M of Offering Proceeds
  • DarioHealth Lands 1.5M-Covered-Lives Contract with Major NJ Health Plan
  • DarioHealth Q2 Revenue Misses by 12%, Pharma Exit Weighs on Top Line

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$22.36M
Net Income
-$41.71M
Diluted EPS
$10.12
Op. Cash Flow
-$25.94M
Free Cash Flow
-$26.08M
Gross Profit
$12.66M
Operating Income
-$36.66M
Cash & Equivalents
$21.8M
Total Debt
$30.75M
Debt / Equity
0.45×
Net Margin
-186.6%
Shares Outstanding
6.91M sh
Source: 10-K · filed 2026-03-19 · accession 0001104659-26-031621

Short Interest & Short Volume

1.21 days to cover

FINRA reported short interest of 114,624 shares in DRIO as of the October 30, 2026 settlement, a 41.1% increase from the prior period — about 1.2 days to cover at its recent average daily volume. On November 20, 2026, 24.2% of DRIO volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)114,624 shares as of October 30, 2026
Change vs prior period▲ 41.1%
Days to cover1.21 at avg daily volume of 95,080
Daily short volume (FINRA facilities)24.2% of 16,876 shares on November 20, 2026
5-day average short volume35.6%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

High risk

Filing-implied dilution signals for DRIO, detected from its recent SEC filings · based on capital-structure filings through 2026-07-22.

1 recent capital raise

$23.5M Registered Direct Offering Priced · Significant Dilution to Existing Holders

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with D →
$1.32
52-week range · as of 2026-11-12 $1.32 – $14.77
Market cap
$14.9M
Volume
28.2K (0.4× avg)
3-mo avg 74.7K
Live data · 2026-11-22 03:42 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed DRIO - Latest Insights

DRIO
Nov 19, 2026, 7:30 AM EST
Source: PR Newswire
Importance Score:
7
Price at Filing: $1.17
Real-time Price: $1.32 info
Change: +$0.1497 (+13%) info
Market Cap: $14.899M info
DRIO
Nov 12, 2026, 6:36 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $2.13
Real-time Price: $1.32 info
Change: -$0.805 (-38%) info
Market Cap: $14.899M info
DRIO
Nov 12, 2026, 6:05 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $2.13
Real-time Price: $1.32 info
Change: -$0.805 (-38%) info
Market Cap: $14.899M info
DRIO
Sep 17, 2026, 7:30 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $6.78
Real-time Price: $1.32 info
Change: -$5.46 (-81%) info
Market Cap: $14.899M info
DRIO
Aug 11, 2026, 6:38 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $7.66
Real-time Price: $1.32 info
Change: -$6.34 (-83%) info
Market Cap: $14.899M info
DRIO
Aug 11, 2026, 6:05 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $7.66
Real-time Price: $1.32 info
Change: -$6.34 (-83%) info
Market Cap: $14.899M info
DRIO
Jul 22, 2026, 5:14 PM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $7.99
Real-time Price: $1.32 info
Change: -$6.67 (-83%) info
Market Cap: $14.899M info
DRIO
Jul 22, 2026, 8:00 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $6.67
Real-time Price: $1.32 info
Change: -$5.35 (-80%) info
Market Cap: $14.899M info
DRIO
Jul 10, 2026, 5:10 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.22
Real-time Price: $1.32 info
Change: -$5.90 (-82%) info
Market Cap: $14.899M info
DRIO
Jul 06, 2026, 7:30 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $7.16
Real-time Price: $1.32 info
Change: -$5.84 (-82%) info
Market Cap: $14.899M info
DRIO
Jul 02, 2026, 7:30 AM EDT
Source: PR Newswire
Importance Score:
9
Price at Filing: $6.60
Real-time Price: $1.32 info
Change: -$5.28 (-80%) info
Market Cap: $14.899M info
DRIO
Jun 29, 2026, 7:00 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $7.03
Real-time Price: $1.32 info
Change: -$5.71 (-81%) info
Market Cap: $14.899M info
DRIO
May 13, 2026, 6:11 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $8.68
Real-time Price: $1.32 info
Change: -$7.36 (-85%) info
Market Cap: $14.899M info
DRIO
May 13, 2026, 6:05 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $8.68
Real-time Price: $1.32 info
Change: -$7.36 (-85%) info
Market Cap: $14.899M info
DRIO
Apr 13, 2026, 8:21 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.96
Real-time Price: $1.32 info
Change: -$5.64 (-81%) info
Market Cap: $14.899M info
DRIO
Mar 30, 2026, 6:14 PM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $8.19
Real-time Price: $1.32 info
Change: -$6.87 (-84%) info
Market Cap: $14.899M info
DRIO
Mar 30, 2026, 5:43 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $8.19
Real-time Price: $1.32 info
Change: -$6.87 (-84%) info
Market Cap: $14.899M info
DRIO
Mar 30, 2026, 5:31 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $8.19
Real-time Price: $1.32 info
Change: -$6.87 (-84%) info
Market Cap: $14.899M info
DRIO
Mar 19, 2026, 5:02 PM EDT
Filing Type: S-3
Importance Score:
9
Price at Filing: $8.24
Real-time Price: $1.32 info
Change: -$6.92 (-84%) info
Market Cap: $14.899M info
DRIO
Mar 19, 2026, 6:05 AM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $8.06
Real-time Price: $1.32 info
Change: -$6.74 (-84%) info
Market Cap: $14.899M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets